CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages

Infect Immun. 1995 Feb;63(2):486-97. doi: 10.1128/iai.63.2.486-497.1995.

Abstract

Taxol, a microtubule stabilizer with anticancer activity, mimics the actions of lipopolysaccharide (LPS) on murine macrophages in vitro. Recently, it was shown that taxol-induced macrophage activation was inhibited by the LPS antagonist Rhodobacter sphaeroides diphosphoryl lipid A (RsDPLA). To investigate the mechanisms of taxol-induced macrophage activation, the present study focused on the interaction of LPS, RsDPLA, and taxol in the activation of and binding to macrophages. Taxol alone induced murine C3H/He macrophages to secrete tumor necrosis factor alpha (TNF) and to produce nitric oxide (NO) with kinetics similar to that of LPS. Macrophages from LPS-hyporesponsive C3H/HeJ mice, in contrast, did not yield any detectable TNF and NO production in response to LPS or taxol. RsDPLA inhibited taxol-induced TNF and NO production from C3H/He macrophages in a dose-dependent manner. The inhibition by RsDPLA was specific for LPS and taxol in that RsDPLA did not inhibit heat-killed Listeria monocytogenes- or zymosan-induced TNF production. Polymyxin B blocked the inhibitory effect of RsDPLA on taxol-induced TNF production. The inhibitory activity of RsDPLA appeared to be reversible since macrophages still responded to taxol in inducing TNF production after the RsDPLA was washed out with phosphate-buffered saline prior to the addition of taxol. Taxol-induced TNF production was not inhibited by colchicine, vinblastine, or 10-deacetylbaccatine III. A mutant cell line, J7.DEF3, defective in expression of a CD14 antigen, responded equally well to taxol by producing TNF as did the parent J774.1 cells. This suggested that the activation of macrophages by taxol does not require CD14. Taxol-induced TNF production by the mutant cells was also inhibited by RsDPLA. 125I-labeled LPS and 3H-labeled taxol was reported to bind to J774.1 cells predominantly via CD14 and microtubules, respectively. The binding of 125I-labeled LPS to J7.DEF3 cells was about 30 to 40% of that to J774.1 cells. The binding of 125I-LPS to J774.1 cells was inhibited by unlabeled LPS and RsDPLA but not by taxol. On the other hand, 3H-labeled taxol bound to both J774.1 cells and J7.DEF3 cells in similar time- and dose-dependent manners. The binding of [3H]taxol to these cells was inhibited by taxol but not by LPS or RsDPLA. Although the binding studies failed to examine cross competition for binding to macrophages, a possible explanation of these results is that LPS, RsDPLA, and taxol share the same molecule(s) on murine macrophages for their functional receptor(s), which is neither CD14 nor tubulin.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens, CD / physiology*
  • Antigens, Differentiation, Myelomonocytic / physiology*
  • Binding Sites
  • Colchicine / pharmacology
  • Female
  • Lipid A / analogs & derivatives*
  • Lipid A / pharmacology
  • Lipopolysaccharide Receptors
  • Lipopolysaccharides / pharmacology*
  • Macrophage Activation / drug effects*
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / physiology*
  • Mice
  • Mice, Inbred C3H
  • Nitric Oxide / biosynthesis*
  • Paclitaxel / pharmacology*
  • Polymyxin B / pharmacology
  • Rhodobacter sphaeroides
  • Taxoids*
  • Triterpenes / pharmacology
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Vinblastine / pharmacology
  • Zymosan / pharmacology

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Lipid A
  • Lipopolysaccharide Receptors
  • Lipopolysaccharides
  • Taxoids
  • Triterpenes
  • Tumor Necrosis Factor-alpha
  • diphosphoryl lipid A
  • Nitric Oxide
  • 10-deacetylbaccatine III
  • Vinblastine
  • Zymosan
  • Polymyxin B
  • Paclitaxel
  • Colchicine